Neuropeptide Y mediates the short-term hypometabolic effect of estrogen deficiency in mice

Neuropeptide Y mediates the short-term hypometabolic effect of estrogen deficiency in mice

Play all audios:

Loading...

Estrogen deficiency increases body weight or total and central adiposity and decreases energy expenditure. Hypothalamic neuropeptide Y (NPY) expression is altered by estrogen deficiency in


rodents, but the long-term consequences on energy homeostasis are unknown.


To investigate the role of NPY in the changes in energy expenditure and physical activity, as well as the associated changes in body weight and composition in response to short-term and


long-term estrogen deficiency.


Sham and ovariectomy (OVX) operations were performed at 8 weeks of age in wild-type (WT) and NPY−/− mice. Energy expenditure, physical activity, body composition and weight, as well as food


intake were measured at 10–18 days (short-term) and 46–54 days (long-term) after OVX.


OVX influences energy homeostasis differently at early compared with later time-points. At the early but not the late time point, OVX in WT mice reduced oxygen consumption and energy


expenditure and tended to reduce resting metabolic rate. Interestingly, these effects of short-term estrogen deficiency were ablated by NPY deletion, with NPY−/− mice exhibiting significant


increases in energy expenditure and resting metabolic rate. In addition to these hypermetabolic effects, OVX NPY−/− mice exhibited significantly lower body weight and whole-body fat mass


relative to OVX WT controls at the short-term but not the long-term time point. Food intake and physical activity were unaltered by OVX, but NPY−/− mice exhibited significant reductions in


these parameters relative to WT.


The effects of estrogen deficiency to reduce energy metabolism are transient, and NPY is critical to this effect as well as the early OVX-induced obesity.


We gratefully acknowledge the staff of the Garvan Institute Biological Testing Facility for facilitation of these experiments. AZ is supported by an Australian Postgraduate Award; IPLW is


supported by the University of New South Wales Postgraduate Award; HH, PB and AS are supported by a Fellowship and Career Development Awards from the National Health and Medical Research


Council (NHMRC) of Australia. The NHMRC has additionally supported this work with grant #596840. Author Contributions: AZ, HH, PAB and AS designed research; AZ, ADN, IPLW, RFE performed


research; AZ and LZ analyzed data; AZ and AS wrote the paper and HH, LZ, JAE and PB provided critical review of the manuscript.


Osteoporosis and Bone Biology, Garvan Institute of Medical Research, St Vincent′s Hospital, Sydney, New South Wales, Australia


A Zengin, I P L Wong, R F Enriquez, J A Eisman & P A Baldock


Neuroscience Program, Garvan Institute of Medical Research, St Vincent′s Hospital, Sydney, New South Wales, Australia


A Zengin, A D Nguyen, I P L Wong, L Zhang, R F Enriquez, H Herzog, P A Baldock & A Sainsbury


Faculty of Medicine, University of NSW, Sydney, New South Wales, Australia


School of Medical Sciences, University of NSW, Sydney, New South Wales, Australia


Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia


Supplementary Information accompanies the paper on International Journal of Obesity website


Anyone you share the following link with will be able to read this content: